Clincosm LogoSign in Get a demo

Chronic Myelogenous Leukemia, BCR-ABL1 Positive

Showing 26 - 37 of 37
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Accelerated Phase Chronic Myelogenous Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic

Terminated
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +3 more
  • Aurora, Colorado
  • +1 more
Apr 1, 2014

Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia Trial in Boston (omacetaxine

Completed
  • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Chronic Phase Chronic Myelogenous Leukemia
  • omacetaxine mepesuccinate
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Harvard Cancer Center
Jun 4, 2013

Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia, Relapsing Chronic Myelogenous

Completed
  • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +2 more
  • oblimersen sodium
  • +2 more
  • Chicago, Illinois
    Cancer and Leukemia Group B
Jun 3, 2013

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute

Completed
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +61 more
  • La Jolla, California
  • +4 more
Mar 26, 2013

Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, AIDS-related Peripheral/Systemic Lymphoma Trial

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +80 more
  • imatinib mesylate
  • pharmacological study
  • Pittsburgh, Pennsylvania
    University of Pittsburgh
Feb 6, 2013

Accelerated Phase Chronic Myelogenous Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Childhood Chronic Myelogenous

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +7 more
  • Arcadia, California
    Children's Oncology Group
Feb 4, 2013

Blastic Phase Chronic Myelogenous Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Relapsing Chronic Myelogenous

Completed
  • Blastic Phase Chronic Myelogenous Leukemia
  • +2 more
  • Los Angeles, California
    University of California at Los Angeles (UCLA )
Jan 23, 2013

Childhood Chronic Myelogenous Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous

Completed
  • Childhood Chronic Myelogenous Leukemia
  • +3 more
  • omacetaxine mepesuccinate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 22, 2013

Blastic Phase Chronic Myelogenous Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Houston (bevacizumab,

Terminated
  • Blastic Phase Chronic Myelogenous Leukemia
  • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • bevacizumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 22, 2013

Accelerated Phase Chronic Myelogenous Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Childhood Chronic Myelogenous

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +4 more
  • imatinib mesylate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 22, 2013

Childhood Chronic Myelogenous Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous

Completed
  • Childhood Chronic Myelogenous Leukemia
  • +2 more
  • imatinib mesylate
  • +2 more
  • Arcadia, California
    Children's Oncology Group
Jan 16, 2013

Accelerated Phase Chronic Myelogenous Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Chronic Myelogenous Leukemia,

Terminated
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +4 more
  • imatinib mesylate
  • +2 more
  • Orange, California
    University of California Medical Center At Irvine-Orange Campus
Jan 11, 2013